Form D — Areteia Therapeutics, Inc.
0001937542-25-000001 · filed 2025-02-21
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $445,000,000
- Total sold
- $360,000,020
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Areteia Therapeutics, Inc.
- CIK
- 1937542
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 101 GLEN LENNOX DR.
CHAPEL HILL, NC 27517 - Phone
- 617-504-0362
Related persons
-
Paul Berns · DirectorChapel Hill, NC Find on LinkedIn ↗
-
Adam Koppel · DirectorChapel Hill, NC Find on LinkedIn ↗
-
Ian Read · DirectorChapel Hill, NC Find on LinkedIn ↗
-
Benjamin Gomez · DirectorChapel Hill, NC Find on LinkedIn ↗
-
Michael E. Bozik · DirectorChapel Hill, NC Find on LinkedIn ↗
-
Stephen Butts · DirectorChapel Hill, NC Find on LinkedIn ↗
-
Jorge Bartolome · Executive OfficerChapel Hill, NC Find on LinkedIn ↗
-
Elyse Stock · DirectorChapel Hill, NC Find on LinkedIn ↗
-
Daniel Becker · DirectorChapel Hill, NC Find on LinkedIn ↗
-
Christopher Courts · Executive OfficerChapel Hill, NC Find on LinkedIn ↗
-
Robin Walker · Executive OfficerChapel Hill, NC Find on LinkedIn ↗
View original on SEC EDGAR.